In a striking case of corporate déjà vu, South African pharmaceutical firm Adcock Ingram is once again the subject of a foreign takeover bid. However, the script has been flipped. Bidvest, the conglomerate that positioned itself as the company’s patriotic saviour over a decade ago, is now orchestrating its sale to an overseas partner. This culminates in a patient power…
Tag: Mergers & Acquisitions
-
Adcock Ingram to Delist Amidst Corporate Changes
Adcock Ingram, the pharmaceutical giant behind household brands such as Panado and Corenza-C, could delist from the Johannesburg Stock Exchange (JSE). This follows a significant deal between its majority shareholder, Bidvest, and Indian drugmaker Natco Pharma. The news saw Adcock’s share price surge by 24%. Under the terms of the agreement, Indian-listed Natco Pharma will acquire a significant minority stake…